Get started
Author

Orsolya Mákos

Observed names: Makos, Orsolya, Orsolya Makos
ORCID: 0000-0003-1525-4524
Observed ORCID: 0000-0003-1525-4524
OpenAlex ID: A5009754978
Study protocol for the iMarkHD study in individuals with Huntington's disease
2024 · Daniel J van Wamelen, Naomi H Martin, et al. · Journal of Huntington s Disease · 4
PDF
LRRK2 mutations in Parkinson's disease patients from Central Europe: A case control study
2021 · Matej Skorvanek, Mie Rizig, et al. · Parkinsonism & Related Disorders · 4
[A new method for the measurement of social cognition in schizophrenia].
2019 · Eszter Varga, Títusz Bugya, et al. · PubMed · 1
Differential task-related fMRI effects of a single dose of guanfacine and lisdexamfetamine in youth with ADHD: a randomised, double-blind, placebo-controlled crossover study
2026 · Sahid El Masri, Olivia S. Kowalczyk, et al. · medRxiv
PDF
Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort
2026 · Katarzyna Smilowska, Orsolya Makos, et al. · Journal of Parkinson s Disease
Comparison of partial volume correction methods integrating PET and MRI data in Huntington's disease
2026 · Manuela Moretto, Giorgia Baldascino, et al. · EANM Innovation
Endocrine biomarkers in Huntington's Disease: Protocol for a scoping review with framework synthesis
2026 · Makos, Orsolya, van Wamelen, Daniel, et al. · Open Science Framework
Differential effects of a single dose of Lisdexamfetamine and Guanfacine on cognitive function in children with ADHD
2025 · Sahid El Masri, Olivia S. Kowalczyk, et al. · Frontiers in Psychiatry
PDF
E003 Update on the iMarkHD study
2024 · Alay Rangel Cristales, Monika Hartmann, et al.
PDF
E002 Interim positron emission scan results from the iMarkHD study
2024 · Manuela Moretto, Mattia Veronese, et al.
Works count: 10
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type